Interaction between interleukin-8 and methylenetetrahydrofolate reductase genes modulates Alzheimer's disease risk

Dement Geriatr Cogn Disord. 2009;27(3):286-91. doi: 10.1159/000204766. Epub 2009 Feb 25.

Abstract

Background/aim: Interleukin-8 (IL-8), a potent chemoattractant for neutrophils, has been implicated in the pathogenesis of Alzheimer's disease (AD). The ability of individuals to produce high levels of IL-8 is partially determined by the IL-8 -251 T/A polymorphism. Therefore, we investigated the association between this polymorphism and AD in a Chinese population. Additionally, in light of the stimulatory effect of homocysteine on the production of IL-8, we also sought to determine whether the methylenetetrahydrofolate reductase (MTHFR) gene 677 C/T variant, a genetic modifier of the serum homocysteine level, may interact with the IL-8 -251 polymorphism in determining the AD risk.

Methods: Genotyping of 198 AD patients and 240 matched controls was performed by PCR-RFLP.

Results: The presence of the MTHFR 677 C/T and 677 T/T genotypes conferred a marginally significant increase in the risk for AD (OR = 1.666, 95% CI = 1.022-2.715, and OR = 1.892, 95% CI = 1.124-3.187) and the presence of the IL-8 -251 polymorphism was not associated with AD. However, the OR for AD associated with joint occurrence of the MTHFR 677 T/T and the IL-8 -251 A/A genotypes was 2.512 (95% CI = 1.151-5.483).

Conclusion: Our data suggest a critical role for IL-8/MTHFR interactions in the development of AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alleles
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / genetics*
  • China / epidemiology
  • Female
  • Gene Frequency
  • Genotype
  • Homocysteine / blood
  • Humans
  • Interleukin-8 / genetics*
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Polymorphism, Genetic / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Risk Assessment

Substances

  • Interleukin-8
  • Homocysteine
  • Methylenetetrahydrofolate Reductase (NADPH2)